Evidence map›Paper›PMID 29346331›Full record

ReviewInternational journal of molecular sciences2018

Growth Hormone (GH) and Cardiovascular System.

Diego Caicedo, Oscar Díaz, Pablo Devesa, Jesús Devesa

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Observational
  6. Sleep loss as a cardiometabolic risk factor: a narrative review of clinical and public health implications.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Diego CaicedoDepartment of Angiology and Vascular Surgery, Complejo Hospitalario Universitario de Pontevedra, 36701 Pontevedra, Spain. diego.caicedo.valdes@sergas.es.ORCID 0000-0002-9599-7047
Oscar DíazDepartment of Cardiology, Complejo Hospitalario Universitario de Pontevedra, 36701 Pontevedra, Spain. oscar.diaz.castro@sergas.es.
Pablo DevesaResearch and Development, The Medical Center Foltra, 15886 Teo, Spain. pdevesap@foltra.org.
Jesús DevesaScientific Direction, The Medical Center Foltra, 15886 Teo, Spain. jesus.devesa@usc.es.ORCID 0000-0002-4153-2543
Complejo Hospitalario de Pontevedra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review describes the positive effects of growth hormone (GH) on the cardiovascular system. We analyze why the vascular endothelium is a real internal secretion gland, whose inflammation is the first step for developing atherosclerosis, as well as the mechanisms by which GH acts on vessels improving oxidative stress imbalance and endothelial dysfunction. We also report how GH acts on coronary arterial disease and heart failure, and on peripheral arterial disease, inducing a neovascularization process that finally increases flow in ischemic tissues. We include some preliminary data from a trial in which GH or placebo is given to elderly people suffering from critical limb ischemia, showing some of the benefits of the hormone on plasma markers of inflammation, and the safety of GH administration during short periods of time, even in diabetic patients. We also analyze how Klotho is strongly related to GH, inducing, after being released from the damaged vascular endothelium, the pituitary secretion of GH, most likely to repair the injury in the ischemic tissues. We also show how GH can help during wound healing by increasing the blood flow and some neurotrophic and growth factors. In summary, we postulate that short-term GH administration could be useful to treat cardiovascular diseases.

Indexed as

Antineoplastic Agents, HormonalCardiovascular DiseasesCytokinesEndothelium, VascularGhrelinGlucuronidaseGrowth HormoneHumansInsulin-Like Growth Factor IKlotho ProteinsOxidative StressAntineoplastic Agents, HormonalCytokinesGhrelinGlucuronidaseGrowth HormoneInsulin-Like Growth Factor IKlotho Proteinsangiogenesis and arteriogenesisatherosclerosiscardiovascular diseasesendothelial dysfunctiongrowth hormoneIGF-Ioxidative stresswound healing

Identifiers

PMID29346331
PMCPMC5796235
OpenAlexW2778371758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.